Related Experiment Video
Updated: Jul 10, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Reducing publication bias of prospective clinical trials through trial registration
Lisa N Abaid1, David A Grimes, Kenneth F Schulz
1Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7570, USA. labaid@med.unc.edu
Abstract:
Publication bias is the selective publishing of favorable or statistically significant results. This practice, over time, distorts the medical literature by depicting inordinately optimistic outcomes for treatments and interventions. Sources of publication bias include preferential publishing by journals and preferential submission by researchers. Mandatory trial registration, as instituted by the International Committe of Medical Journal Editors (ICMJE), should reduce publication bias by improving the ability to identify all trials pertaining to a specific intervention. Contraception endorses the views of the ICMJE and will now require registration of all prospective trials.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blinding
Hazard Ratio
For example, in a clinical trial evaluating a...
Blind Procedures
